Announcement

Collapse
No announcement yet.

Autoimmune disease biotech Kyverna Therapeutics ups deal size by 49% ahead of $297 million IPO

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Autoimmune disease biotech Kyverna Therapeutics ups deal size by 49% ahead of $297 million IPO

     This content is restricted, Login to view or sign up
X
Working...
X